
Read More
Large-Cap Injectable-Focused Pharma Company Gains USFDA Nod for Key Pain Ma...
With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The co...

With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The co...

With its particular acclaim for sterile injectables, oncology and ophthalmic products, the company h...

With times like these, investors shouldn’t panic and keep a close eye on the fundamentally strong co...

On Wednesday, the domestic equity markets were driven majorly by events namely the commencement of t...

On Thursday, the bulls took the charge and forced the benchmark indices to close on a higher note. T...